Efficacy of Nardostachys Jatamansi DC as an adjuvant to escitalopram in the treatment of major depressive disorder – A randomized double-blind placebo-controlled study

IF 3.8 4区医学 Q1 PSYCHIATRY

Asian journal of psychiatry Pub Date : 2025-07-04 DOI:10.1016/j.ajp.2025.104611

VS Jismi, Kishore Kumar Ramakrishna, Urvakhsh Meherwan Mehta , Shivarama Varambally , Venkataram Shivakumar , Talakad N. Sathyaprabha , Kaviraja Udupa

引用次数: 0

查看原文本刊更多论文

Nardostachys Jatamansi DC作为艾司西酞普兰辅助治疗重度抑郁症的疗效——一项随机双盲安慰剂对照研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian journal of psychiatry Medicine-Psychiatry and Mental Health

CiteScore

12.70

自引率

5.30%

发文量

297

审稿时长

35 days

期刊介绍： The Asian Journal of Psychiatry serves as a comprehensive resource for psychiatrists, mental health clinicians, neurologists, physicians, mental health students, and policymakers. Its goal is to facilitate the exchange of research findings and clinical practices between Asia and the global community. The journal focuses on psychiatric research relevant to Asia, covering preclinical, clinical, service system, and policy development topics. It also highlights the socio-cultural diversity of the region in relation to mental health.